Search research articles
Contact Us
Filters
Showing results (181-190 of 339) with videos related to
Page
of 34
Sort By:
Leukemia Research
|
May 14, 2021
Eligibility for clinical trials is unsatisfactory for patients with myelodysplastic syndromes, even at a tertiary referral center
Kathrin Nachtkamp, Josefine Stark, Andrea Kündgen, et al.
Blood
|
July 20, 2007
Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes
Azim Mohamedali, Joop Gäken, Natalie A Twine, et al.
Cancers
|
June 19, 2024
Overlapping Stromal Alterations in Myeloid and Lymphoid Neoplasms
Lucienne Bogun, Annemarie Koch, Bo Scherer, et al.
Leukemia Research
|
January 4, 2019
Additional prognostic impact of the percentage of erythroid cells in the bone marrow of patients with myelodysplastic syndromes
Judith Neukirchen-Strapatsas, Heinz Tuechler, Matteo Della Porta, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 23, 2008
Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS)
Uwe Platzbecker, Martin Bornhäuser, Ulrich Germing, et al.
Haematologica
|
August 10, 2012
Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome
Barbara Deschler, Gabriele Ihorst, Uwe Platzbecker, et al.
Cancers
|
February 10, 2024
Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies
Felicitas Schulz, Paul Jäger, Johanna Tischer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 15, 2012
Allogeneic hematopoietic cell transplantation in patients age 60-70 years with de novo high-risk myelodysplastic syndrome or secondary acute myelogenous leukemia: comparison with patients lacking donors who received azacitidine
Uwe Platzbecker, Johannes Schetelig, Jürgen Finke, et al.
Experimental Hematology
|
November 9, 2002
Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioning
Guido Kobbe, Peter Schneider, Manuel Aivado, et al.
Ejhaem
|
March 5, 2025
Haploidentical Allogeneic Stem Cell Transplantation as a Superior Alternative for Patients With Mismatch Donors-A Single Center Experience in 152 Patients
Paul Jäger, Benno Biermann, Nora Liebers, et al.
Page
of 34
Search research articles
Search
Showing results (181-190 of 339) with videos related to
Sort By:
Page
of 34
Leukemia Research
|
May 14, 2021
Eligibility for clinical trials is unsatisfactory for patients with myelodysplastic syndromes, even at a tertiary referral center
Kathrin Nachtkamp, Josefine Stark, Andrea Kündgen, et al.
Blood
|
July 20, 2007
Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes
Azim Mohamedali, Joop Gäken, Natalie A Twine, et al.
Cancers
|
June 19, 2024
Overlapping Stromal Alterations in Myeloid and Lymphoid Neoplasms
Lucienne Bogun, Annemarie Koch, Bo Scherer, et al.
Leukemia Research
|
January 4, 2019
Additional prognostic impact of the percentage of erythroid cells in the bone marrow of patients with myelodysplastic syndromes
Judith Neukirchen-Strapatsas, Heinz Tuechler, Matteo Della Porta, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 23, 2008
Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS)
Uwe Platzbecker, Martin Bornhäuser, Ulrich Germing, et al.
Haematologica
|
August 10, 2012
Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome
Barbara Deschler, Gabriele Ihorst, Uwe Platzbecker, et al.
Cancers
|
February 10, 2024
Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies
Felicitas Schulz, Paul Jäger, Johanna Tischer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 15, 2012
Allogeneic hematopoietic cell transplantation in patients age 60-70 years with de novo high-risk myelodysplastic syndrome or secondary acute myelogenous leukemia: comparison with patients lacking donors who received azacitidine
Uwe Platzbecker, Johannes Schetelig, Jürgen Finke, et al.
Experimental Hematology
|
November 9, 2002
Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioning
Guido Kobbe, Peter Schneider, Manuel Aivado, et al.
Ejhaem
|
March 5, 2025
Haploidentical Allogeneic Stem Cell Transplantation as a Superior Alternative for Patients With Mismatch Donors-A Single Center Experience in 152 Patients
Paul Jäger, Benno Biermann, Nora Liebers, et al.
Page
of 34